Barış Türkbey

OncoBERT models somatic mutations in cancer to identify patient-specific subtypes and improve prediction of treatment response by integrating mutational context with clinical biomarkers.

HistoTME-v2 predicts cell type-specific transcriptomic signatures and spatial distributions from H&E images, outperforming baselines across 25 tumor types and multiple validation datasets.